completely agree that it’s optimistic to think that could occur...

completely agree that it’s optimistic to think that could occur in a year but maybe 3. On the other hand the cash comparison isn’t really a fair one either - their burn rate is also multiples of PYC and they say even with all that cash and extra payment they only last till mid 2024 which is what someone reported PYC said on a recent call? Cash in biotech I have learned should never be taken out to calculate a net MCAP - just a survival runway. If PYC can have the same amount of programs in 3 years time then it’s MCAP should be much higher than Stoke cause it is producing the same potential income stream at a far far cheaper cost.

and pigs may fly . . .

but we are trying to buy some cause we love bacon and think the FDA news has been underestimated.